Results: 5

1.
FIGURE 3

FIGURE 3. From: Improved Outcomes in a Quality Improvement Collaborative for Pediatric Inflammatory Bowel Disease.

Disease severity for CD and UC (monthly change in disease severity over time). Changes in disease activity were primarily associated with a decrease in the percentage of patients with mild disease.

Wallace V. Crandall, et al. Pediatrics. 2012 April;129(4):e1030-e1041.
2.
FIGURE 5

FIGURE 5. From: Improved Outcomes in a Quality Improvement Collaborative for Pediatric Inflammatory Bowel Disease.

Characteristics of CD and UC patients at the time of enrollment (change in remission rates, gender, BMI, and time from diagnosis for patients enrolled in the study over time). There was no change in gender proportions at the time of enrollment. There was a minor increase in BMI among UC patients. The time from diagnosis to enrollment decreased over the course of the collaborative.

Wallace V. Crandall, et al. Pediatrics. 2012 April;129(4):e1030-e1041.
3.
FIGURE 1

FIGURE 1. From: Improved Outcomes in a Quality Improvement Collaborative for Pediatric Inflammatory Bowel Disease.

Process measures for CD and UC. Top charts show the proportion of monthly visits with a complete standardized assessment bundle; middle charts show the proportion of patients who received a starting dose of thiopurine appropriate to their TPMT status; and bottom charts show the proportion of patients in whom TPMT was measured before initiation of thiopurine. Each chart shows change over time by quarter (Q) and year. Changes in care delivery were associated with improvements in the processes of care.

Wallace V. Crandall, et al. Pediatrics. 2012 April;129(4):e1030-e1041.
4.
FIGURE 4

FIGURE 4. From: Improved Outcomes in a Quality Improvement Collaborative for Pediatric Inflammatory Bowel Disease.

Percent of CD and UC patients not taking prednisone (annotated control charts showing monthly results for all centers combined). The dotted centerline represents the mean proportion. The dashed upper and lower control limits reflected the inherent variation in the data and were calculated as ±3 SD of the centerline proportion. The proportion of CD patients, but not UC patients, increased over time. A, uniform practices developed; B, key driver diagram presented, population management report, previsit planning, protocols and auditing, nutrition and growth algorithm; C, standardized assessment bundle; D, Model IBD Care Guideline; E, introduction to self-management support.

Wallace V. Crandall, et al. Pediatrics. 2012 April;129(4):e1030-e1041.
5.

FIGURE 2. From: Improved Outcomes in a Quality Improvement Collaborative for Pediatric Inflammatory Bowel Disease.

Patients with inactive disease, as assessed by PGA, overall and for each practice site. The top charts are annotated control charts showing monthly results for all centers combined. The dotted centerline represents the mean proportion. The dashed upper and lower control limits reflected the inherent variation in the data and were calculated as ±3 SD of the centerline proportion. The lower charts show results for each center over the same time period. The proportion of patients with inactive disease increased over time. A, uniform practices developed; B, key driver diagram presented, population management report, previsit planning, protocols and auditing, nutrition and growth algorithm; C, standardized assessment bundle; D, Model IBD Care Guideline; E, introduction to self-management support.

Wallace V. Crandall, et al. Pediatrics. 2012 April;129(4):e1030-e1041.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk